{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:04:59Z","timestamp":1759104299475},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T00:00:00Z","timestamp":1273276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10151-010-0574-3","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T19:15:47Z","timestamp":1273259747000},"page":"97-105","source":"Crossref","is-referenced-by-count":20,"title":["Review of medical and surgical management of Clostridium difficile infection"],"prefix":"10.1007","volume":"14","author":[{"given":"B.","family":"Faris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blackmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Haboubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,8]]},"reference":[{"key":"574_CR1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(05)70215-2","volume":"5","author":"S Aslam","year":"2005","unstructured":"Aslam S, Hamill RJ, Musher DM (2005) Treatment of Clostridium difficile associated disease: old therapies and new strategies. Lancet Infect Dis 5:549\u2013557","journal-title":"Lancet Infect Dis"},{"key":"574_CR2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM198901263200402","volume":"320","author":"LV McFarland","year":"1989","unstructured":"McFarland LV, Mulligan ME, Kwok RY, Stamm WE (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320:204\u2013210","journal-title":"N Engl J Med"},{"key":"574_CR3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archpedi.1935.01970020105010","volume":"48","author":"IC Hall","year":"1935","unstructured":"Hall IC, O\u2019Toole E (1935) Intestinal flora in newborn infants with a description of a new pathogenic anaerobe: Bacillus difficilis. Am J Dis Child 48:390\u2013402","journal-title":"Am J Dis Child"},{"key":"574_CR4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200009000-00004","volume":"31","author":"LV McFarland","year":"2000","unstructured":"McFarland LV, Brandmarker SA, Guandalini S (2000) Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gastroenterol Nutr 31:220\u2013231","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"574_CR5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/521854","volume":"45","author":"MM Riggs","year":"2007","unstructured":"Riggs MM, Sethi AK, Zabarsky TF et al (2007) Asymptomatic carriers are a potential source for transmission of epidemic and non-epidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 45:992\u2212998","journal-title":"Clin Infect Dis"},{"key":"574_CR6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","volume":"342","author":"L Kyne","year":"2000","unstructured":"Kyne L, Warny M, Qamar A, Kelly CP (2000) Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342:390\u2212397","journal-title":"N Engl J Med"},{"key":"574_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3949\/ccjm.73.2.187","volume":"73","author":"RH Sunenshine","year":"2006","unstructured":"Sunenshine RH, McDonald LC (2006) Clostridium difficile-associated disease: new challenges from an established pathogen. Cleveland Clinic J Med 73:187\u2212197","journal-title":"Cleveland Clinic J Med"},{"key":"574_CR8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/archinte.162.19.2177","volume":"162","author":"BW Hurley","year":"2002","unstructured":"Hurley BW, Nguyen CC (2002) The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhoea. Arch Intern Med 162:2177\u20132184","journal-title":"Arch Intern Med"},{"key":"574_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/338260","volume":"34","author":"L Kyne","year":"2002","unstructured":"Kyne L, Hamel MB, Polavaram R, Kelly CP (2002) Healthcare costs and mortality associated with nosocomial diarrhoea due to Clostridium difficile. Clin Infect Dis 34:346\u2013353","journal-title":"Clin Infect Dis"},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1521-6918(03)00017-9","volume":"17","author":"MH Wilcox","year":"2003","unstructured":"Wilcox MH (2003) Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 17:475\u2013493","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"574_CR11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/clinids\/16.Supplement_4.S214","volume":"16","author":"KH Wilson","year":"1993","unstructured":"Wilson KH (1993) The micro ecology of Clostridium difficile. Clin Infect Dis 16:214\u2013218","journal-title":"Clin Infect Dis"},{"key":"574_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM199401273300406","volume":"330","author":"CP Kelly","year":"1994","unstructured":"Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330:257\u2013262","journal-title":"N Engl J Med"},{"key":"574_CR13","first-page":"850","volume":"57","author":"T Monaghan","year":"2008","unstructured":"Monaghan T, Boswell T, Mahida YR et al (2008) Recent advances in Clostridium difficile-associated disease. Gut 57:850\u2013860","journal-title":"Gut"},{"key":"574_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","volume":"40","author":"GE Bignardi","year":"1998","unstructured":"Bignardi GE (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40:1\u201315","journal-title":"J Hosp Infect"},{"key":"574_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/DCR.0b013e31819733fd","volume":"52","author":"R Ricciardi","year":"2009","unstructured":"Ricciardi R, Ogilvie JW, Roberts PL, Marcello PW, Concannon TW, Baxter NN (2009) Epidemiology of Clostridium difficile Colitis in hospitalised patients with inflammatory bowel disease. Dis Colon Rectum 52:40\u201345","journal-title":"Dis Colon Rectum"},{"key":"574_CR16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/pgmj.2004.028480","volume":"81","author":"I Tonna","year":"2005","unstructured":"Tonna I, Welsby PD (2005) Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J 81:367\u2013369","journal-title":"Postgrad Med J"},{"key":"574_CR17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jac\/dkn163","volume":"62","author":"MH Wilcox","year":"2008","unstructured":"Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN (2008) A case\u2013control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 62:388\u2013396","journal-title":"J Antimicrob Chemother"},{"key":"574_CR18","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1572-0241.2008.01975.x","volume":"103","author":"M Aseeri","year":"2008","unstructured":"Aseeri M, Schroeder T, Kramer J et al (2008) Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile associated diarrhoea in hospitalised patients. Am J Gastroenterol 103:2308\u20132313","journal-title":"Am J Gastroenterol"},{"key":"574_CR19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1503\/cmaj.071812","volume":"179","author":"S Dial","year":"2008","unstructured":"Dial S, Kezouh A, Dascal A, Barkun A, Suissa S (2008) Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 179:767\u2013772","journal-title":"CMAJ"},{"key":"574_CR20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J Leonard","year":"2007","unstructured":"Leonard J, Marshall JK, Moayyedi P (2007) Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 102:2047\u20132056","journal-title":"Am J Gastroenterol"},{"key":"574_CR21","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1086\/508453","volume":"43","author":"D Lowe","year":"2006","unstructured":"Lowe D, Mamdani MM, Kopp A, Low DE, Juurlink DN (2006) Proton pump inhibitors and hospitalisation for Clostridium difficile associated disease: a population-based study. Clin Infect Dis 43:1272\u20131276","journal-title":"Clin Infect Dis"},{"key":"574_CR22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11605-008-0569-9","volume":"12","author":"JL Hermsen","year":"2008","unstructured":"Hermsen JL, Dobrescu C, Kudsk KA (2008) Clostridium difficile: a surgical disease in evolution. J Gastrointest Surg 12:1512\u20131517","journal-title":"J Gastrointest Surg"},{"key":"574_CR23","first-page":"40","volume":"5","author":"LV McFarland","year":"2008","unstructured":"McFarland LV (2008) Update on the changing epidemiology of Clostridium difficile\u2014associated disease. Nature Clin Pract 5:40\u201348","journal-title":"Nature Clin Pract"},{"key":"574_CR24","first-page":"304","volume":"83","author":"GW Burke","year":"1988","unstructured":"Burke GW, Wilson ME, Mehrez IQ (1988) Absence of diarrhoea in toxic megacolon complicating Clostridium difficile pseudomembranous colitis. Am J Gastroent 83:304\u2013307","journal-title":"Am J Gastroent"},{"key":"574_CR25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0002-9610(05)81024-4","volume":"160","author":"YK Viswanath","year":"1990","unstructured":"Viswanath YK, Griffith CD (1990) Role of surgery in antibiotic induced pseudomembranous colitis. Am J Surg 160:535\u2013539","journal-title":"Am J Surg"},{"key":"574_CR26","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/clinids\/12.Supplement_2.S243","volume":"12","author":"JG Bartlett","year":"1990","unstructured":"Bartlett JG (1990) Clostridium difficile: clinical considerations. Rev Infect Dis 12:S243\u2013S251","journal-title":"Rev Infect Dis"},{"key":"574_CR27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","volume":"346","author":"JG Bartlett","year":"2002","unstructured":"Bartlett JG (2002) Clinical practice: antibiotic-associated diarrhea. N Eng J Med 346:334\u2013339","journal-title":"N Eng J Med"},{"key":"574_CR28","unstructured":"Clostridium difficile infection (2008) How to deal with the problem, a board to ward approach. Department of Health Steering Group on Healthcare Associated Infection. Department of Health; Gateway Reference 9833"},{"key":"574_CR29","unstructured":"Diagnosis, Treatment, and Management of CDI (2008) An Expert Interview with Cassandra D. Salgado, MD, MS. Medscape Infectious Diseases. http:\/\/www.medscape.com\/viewarticle\/576542"},{"key":"574_CR30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1503\/cmaj.050978","volume":"173","author":"J P\u00e9pin","year":"2005","unstructured":"P\u00e9pin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile\u2013associated disease during an epidemic caused by a hyper virulent strain in Quebec. CMAJ 173:1037\u20131042","journal-title":"CMAJ"},{"key":"574_CR31","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"LC McDonald","year":"2005","unstructured":"McDonald LC, Kilgore GE, Thompson A et al (2005) An epidemic, toxin gene variant strain of Clostridium difficile. N Engl J Med 353:2433\u20132441","journal-title":"N Engl J Med"},{"key":"574_CR32","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1365-2958.2007.05739.x","volume":"64","author":"S Matamouros","year":"2007","unstructured":"Matamouros S, England P, Dupuy B (2007) Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 64:1274\u20131288","journal-title":"Mol Microbiol"},{"key":"574_CR33","first-page":"4","volume":"23","author":"J Cloud","year":"2007","unstructured":"Cloud J, Kelly CP (2007) Update on Clostridium difficile associated disease. Cur Opin Gastroenterol 23:4\u20139","journal-title":"Cur Opin Gastroenterol"},{"key":"574_CR34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/QCO.0b013e32818be71d","volume":"20","author":"EJ Kuijper","year":"2007","unstructured":"Kuijper EJ, van Dissel JT, Wilcox MH (2007) Clostridium difficile: changing epidemiology and new treatment options. Cur Opin Infect Dis 20:376\u2013383","journal-title":"Cur Opin Infect Dis"},{"key":"574_CR35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/510391","volume":"44","author":"B Hubert","year":"2007","unstructured":"Hubert B, Loo VG, Bourgault AM et al (2007) A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile associated disease in Quebec. Clin Infect Dis 44:238\u2013244","journal-title":"Clin Infect Dis"},{"key":"574_CR36","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","volume":"366","author":"M Warny","year":"2005","unstructured":"Warny M, Pepin J, Fang A et al (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079\u20131084","journal-title":"Lancet"},{"key":"574_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.41.19000-en","volume":"13","author":"JS Brazier","year":"2008","unstructured":"Brazier JS, Raybould R, Patel B et al (2008) Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007\u201308. Euro Surveill 13:1\u20134","journal-title":"Euro Surveill"},{"key":"574_CR38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","volume":"47","author":"A Goorhuis","year":"2008","unstructured":"Goorhuis A, Bakker D, Corver J et al (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47:1162\u20131170","journal-title":"Clin Infect Dis"},{"key":"574_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0195-6701(96)90122-X","volume":"34","author":"MH Wilcox","year":"1996","unstructured":"Wilcox MH, Cunniffe JG, Trundle C, Redpath C (1996) Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34:23\u201330","journal-title":"J Hosp Infect"},{"key":"574_CR40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1308\/003588409X432310","volume":"91","author":"A Somaiah","year":"2009","unstructured":"Somaiah A, Blencowe N, PYE G, West R (2009) Clostridium difficile: how much do hospital staff know about it. Ann R Coll Surg Engl 91:464\u2013469","journal-title":"Ann R Coll Surg Engl"},{"key":"574_CR41","unstructured":"Deaths involving Clostridium difficile; England and Wales, 2003-2007 (2008) Health Stat Q:67\u201376"},{"key":"574_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0095-4543(02)00060-X","volume":"30","author":"A Jabbar","year":"2003","unstructured":"Jabbar A, Wright RA (2003) Gastroenteritis and antibiotic-associated diarrhoea. Prim Care 30:63\u201380","journal-title":"Prim Care"},{"key":"574_CR43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0889-8553(05)70209-0","volume":"30","author":"L Kyne","year":"2001","unstructured":"Kyne L, Farrel RJ, Kelly CP (2001) Clostridium difficile. Gastroenterol Clin North Am 30:753\u2013777","journal-title":"Gastroenterol Clin North Am"},{"key":"574_CR44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","volume":"32","author":"RL Guerrant","year":"2001","unstructured":"Guerrant RL, Van Gilder T, Steiner TS et al (2001) Practice guidelines for the management of infectious diarrhoea. Clin Infect Dis 32:331\u2013351","journal-title":"Clin Infect Dis"},{"key":"574_CR45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2307\/30141083","volume":"16","author":"DN Gerding","year":"1995","unstructured":"Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr (1995) Clostridium difficile-associated disease diarrhoea and colitis. Infect Control Hosp Epidemiol 16:459\u2013477","journal-title":"Infect Control Hosp Epidemiol"},{"key":"574_CR46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1086\/518874","volume":"45","author":"DB Blossom","year":"2007","unstructured":"Blossom DB, McDonald LC (2007) The challenges posed by re-emerging Clostridium difficile infection. Clin Infect Dis 45:222\u2013227","journal-title":"Clin Infect Dis"},{"key":"574_CR47","unstructured":"NHS Purchasing and Supply Agency, Centre for Evidence-based Purchasing (CEP) (2008) Evaluation Report on Clostridium difficile toxin detection assays. CEP08054"},{"key":"574_CR48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/JCM.01503-07","volume":"49","author":"L Fenner","year":"2008","unstructured":"Fenner L, Widmer AF, Goy G et al (2008) Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. Clin Microbiol 49:328\u2013330","journal-title":"Clin Microbiol"},{"key":"574_CR49","doi-asserted-by":"crossref","unstructured":"Finney JMT (1990) Gastro-enterostomy for cicatrising ulcer of the pylorus. Bull John Hopkins Hospital 4:53\u201355 (1893) (cited by Bartlett JG. Clostridium difficile: clinical considerations. Rev Infect Dis 12:S243-S251)","DOI":"10.1093\/clinids\/12.Supplement_2.S243"},{"key":"574_CR50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","volume":"298","author":"JG Bartlett","year":"1978","unstructured":"Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298:531\u2013534","journal-title":"N Engl J Med"},{"key":"574_CR51","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1445-2197.1996.tb00815.x","volume":"66","author":"FCS Chen","year":"1994","unstructured":"Chen FCS, Woods R (1994) Pseudomembranous pan-enteritis and septicaemia in a patient with ulcerative colitis. ANZ J of Surg 66:565\u2013567","journal-title":"ANZ J of Surg"},{"key":"574_CR52","first-page":"548","volume":"60","author":"LL Morris","year":"1994","unstructured":"Morris LL, Villalba MR, Glover JL (1994) Management of pseudomembranous colitis. Am Surg 60:548\u2013551","journal-title":"Am Surg"},{"key":"574_CR53","doi-asserted-by":"crossref","unstructured":"Goulston SJM, McGovern VJ (1965) Pseudomembranous colitis. Gut 6:207\u2013212","DOI":"10.1136\/gut.6.3.207"},{"key":"574_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.30.1.1","volume":"30","author":"AB Price","year":"1977","unstructured":"Price AB, Davies DR (1977) Pseudomembranous colitis. J Clin Pathol 30:1\u201312","journal-title":"J Clin Pathol"},{"key":"574_CR55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10151-008-0402-1","volume":"12","author":"FA Yafi","year":"2008","unstructured":"Yafi FA, Selvasekar CR, Cima RR (2008) Clostridium difficile enteritis following total colectomy. Tech Coloproctol 12:73\u201374","journal-title":"Tech Coloproctol"},{"key":"574_CR56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/41.suppl_3.13","volume":"41","author":"SP Borriello","year":"1998","unstructured":"Borriello SP (1998) Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother 41:13\u201319","journal-title":"J Antimicrob Chemother"},{"key":"574_CR57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0016-5085(79)90280-4","volume":"77","author":"FJ Tedesco","year":"1979","unstructured":"Tedesco FJ (1979) Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology 77:295\u2013297","journal-title":"Gastroenterology"},{"key":"574_CR58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0016-5085(91)90526-Q","volume":"101","author":"G Triadafilopoulos","year":"1991","unstructured":"Triadafilopoulos G, Hallstone AE (1991) Acute abdomen as the first presentation of pseudomembranous colitis. Gastroenterology 101:685\u2013691","journal-title":"Gastroenterology"},{"key":"574_CR59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/41.suppl_3.5","volume":"41","author":"RC Spencer","year":"1998","unstructured":"Spencer RC (1998) Clinical impact and associated costs of Clostridium difficile associated disease. J Antimicrob Chemother 41:5\u201312","journal-title":"J Antimicrob Chemother"},{"key":"574_CR60","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","volume":"235","author":"RM Dallal","year":"2002","unstructured":"Dallal RM, Harbrecht BG, Boujoukas AJ et al (2002) Fulminant Clostridium difficile: an under appreciated and increasing cause of death and complications. Ann Surg 235:363\u2013372","journal-title":"Ann Surg"},{"key":"574_CR61","unstructured":"Mallavarapu RK, Katner HP (2007) Clostridium difficile\u2014associated diarrhoea and colitis in the hospitalised patient. Hosp Physician 21\u201327"},{"key":"574_CR62","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0889-8553(05)70209-0","volume":"30","author":"L Kyne","year":"2001","unstructured":"Kyne L, Farrell RJ, Kelly CP (2001) Clostridium difficile. Gastroenterol Clin North 30:753\u2013777","journal-title":"Gastroenterol Clin North"},{"key":"574_CR63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","volume":"171","author":"SM Poutanen","year":"2004","unstructured":"Poutanen SM, Simor AE (2004) Clostridium difficile-associated diarrhoea in adults. CMAJ 171:51\u201358","journal-title":"CMAJ"},{"key":"574_CR64","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0016-5085(82)80136-4","volume":"83","author":"FJ Tedesco","year":"1982","unstructured":"Tedesco FJ, Corless JK, Brownstein RE (1982) Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology 83:1259\u20131260","journal-title":"Gastroenterology"},{"key":"574_CR65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9343(03)00420-0","volume":"115","author":"A Wanahita","year":"2003","unstructured":"Wanahita A, Goldsmith EA, Marino BJ, Musher DM (2003) Clostridium difficile infection in patients with unexplained leucocytosis. Am J Med 115:543\u2013546","journal-title":"Am J Med"},{"key":"574_CR66","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1086\/340536","volume":"34","author":"A Wanahita","year":"2002","unstructured":"Wanahita A, Goldsmith EA, Musher DM (2002) Conditions associated with leucocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis 34:1585\u20131592","journal-title":"Clin Infect Dis"},{"key":"574_CR67","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/0003-4819-123-11-199512010-00004","volume":"123","author":"YC Manabe","year":"1995","unstructured":"Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG (1995) Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med 123:835\u2013840","journal-title":"Ann Intern Med"},{"key":"574_CR68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/clind\/15.4.573","volume":"15","author":"JG Bartlett","year":"1992","unstructured":"Bartlett JG (1992) Antibiotic-associated diarrhoea. Clin Infect Dis 15:573\u2013581","journal-title":"Clin Infect Dis"},{"key":"574_CR69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/jmm.0.45753-0","volume":"54","author":"LV McFarland","year":"2005","unstructured":"McFarland LV (2005) Alternative treatments for Clostridium difficile disease: what really works? J Med Microbiol 54:101\u2013111","journal-title":"J Med Microbiol"},{"key":"574_CR70","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3476(05)83393-1","volume":"118","author":"DY Leung","year":"1991","unstructured":"Leung DY, Kelly CP, Boguniewicz M et al (1991) Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118:633\u2013637","journal-title":"J Pediatr"},{"key":"574_CR71","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.71.3.1608-1610.2003","volume":"71","author":"S Aboudola","year":"2003","unstructured":"Aboudola S, Kotloff KL, Kyne L et al (2003) Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun 71:1608\u20131610","journal-title":"Infect Immun"},{"key":"574_CR72","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/00042737-199611000-00004","volume":"8","author":"CP Kelly","year":"1996","unstructured":"Kelly CP (1996) Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol 8:1048\u20131053","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"574_CR73","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/24.3.324","volume":"24","author":"R Fekety","year":"1997","unstructured":"Fekety R, McFarland LV, Surawicz CM et al (1997) Recurrent Clostridium difficile diarrhoea: characteristics of and risk factors for patients enrolled in a prospective, randomised, double-blinded trial. Clin Infect Dis 24:324\u2013333","journal-title":"Clin Infect Dis"},{"key":"574_CR74","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","volume":"97","author":"LV McFarland","year":"2002","unstructured":"McFarland LV, Elmer GW, Surawicz CM (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97:1769\u20131775","journal-title":"Am J Gastroenterol"},{"key":"574_CR75","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","volume":"44","author":"S Johnson","year":"2007","unstructured":"Johnson S, Schriever C, Galang M et al (2007) Interruption of recurrent Clostridium difficile-associated diarrhoea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 44:846\u2013848","journal-title":"Clin Infect Dis"},{"key":"574_CR76","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/pgmj.74.870.216","volume":"74","author":"YK Viswanath","year":"1998","unstructured":"Viswanath YK, Griffiths CD (1998) The role of surgery in pseudomembranous enterocolitis. Postgrad Med J 74:216\u2013219","journal-title":"Postgrad Med J"},{"key":"574_CR77","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1086\/519257","volume":"45","author":"MA Miller","year":"2007","unstructured":"Miller MA (2007) Clinical management of Clostridium difficile-associated disease. Clin Infect Dis 45:S122\u2013S128","journal-title":"Clin Infect Dis"},{"key":"574_CR78","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","volume":"171","author":"J P\u00e9pin","year":"2004","unstructured":"P\u00e9pin J, Valiquette L, Alary ME et al (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171:466\u2013472","journal-title":"CMAJ"},{"key":"574_CR79","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.1976.03260400017019","volume":"235","author":"E Novak","year":"1976","unstructured":"Novak E, Lee JG, Seckman CE et al (1976) Unfavorable effect of atropinediphenoxylate (Lomotil) therapy in lincomycin-caused diarrhea. JAMA 235:1451\u20131454","journal-title":"JAMA"},{"key":"574_CR80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","volume":"171","author":"SM Poutanen","year":"2004","unstructured":"Poutanen SM, Simor AE (2004) Clostridium difficile-associated diarrhea in adults. Can Med Assoc J 171:51\u201358","journal-title":"Can Med Assoc J"},{"key":"574_CR81","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1469-0691.2005.01165.x","volume":"11","author":"E Bouza","year":"2005","unstructured":"Bouza E, Munoz P, Alonso R (2005) Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clin Microbiol Infect 11:S57\u2013S64","journal-title":"Clin Microbiol Infect"},{"key":"574_CR82","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"FA Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM, Davis MB (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 45:302\u2013307","journal-title":"Clin Infect Dis"},{"key":"574_CR83","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/501126","volume":"42","author":"J P\u00e9pin","year":"2006","unstructured":"P\u00e9pin J, Routhier S, Gagnon S, Brazeau I (2006) Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 42:758\u2013764","journal-title":"Clin Infect Dis"},{"key":"574_CR84","unstructured":"Louie T, Gerson M, Grimard D et al (2007) Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile associated diarrhea. 47th Interscience conference on antimicrobial agents and chemotherapy, Chicago"},{"key":"574_CR85","unstructured":"Bouza E, Dryden M, Mohammed R et al (2008) Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhea. 18th European congress of clinical microbiology and infectious diseases"},{"key":"574_CR86","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/j.1572-0241.2007.01539.x","volume":"102","author":"J P\u00e9pin","year":"2007","unstructured":"P\u00e9pin J, Valiquette L, Gagnon S et al (2007) Outcomes of Clostridium difficile associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1\/027. Am J Gastroenterol 102:2781\u20132788","journal-title":"Am J Gastroenterol"},{"key":"574_CR87","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J P\u00e9pin","year":"2005","unstructured":"P\u00e9pin J, Saheb N, Coulombe MA et al (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41:1254\u20131260","journal-title":"Clin Infect Dis"},{"key":"574_CR88","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jac\/36.4.673","volume":"36","author":"MH Wilcox","year":"1995","unstructured":"Wilcox MH, Howe R (1995) Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicrob Chemother 36:673\u2013679","journal-title":"J Antimicrob Chemother"},{"key":"574_CR89","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","volume":"40","author":"DM Musher","year":"2005","unstructured":"Musher DM, Aslam S, Logan N et al (2005) Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40:1586\u20131590","journal-title":"Clin Infect Dis"},{"key":"574_CR90","volume-title":"Metronidazole and vancomycin outcomes for Clostridium difficile-associated diarrhoea in a US hospital database","author":"BJ Lahue","year":"2007","unstructured":"Lahue BJ, Davidson DM (2007) Metronidazole and vancomycin outcomes for Clostridium difficile-associated diarrhoea in a US hospital database. European Conference on Clinical Microbiology and Infectious Diseases, Munich"},{"key":"574_CR91","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","volume":"36","author":"J Aas","year":"2003","unstructured":"Aas J, Ce Gessert, Bakken JS (2003) Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via nasogastric tube. Clin Infect Dis 36:580\u2013585","journal-title":"Clin Infect Dis"},{"key":"574_CR92","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.vaccine.2003.11.030","volume":"22","author":"PJ Giannasca","year":"2004","unstructured":"Giannasca PJ, Wary M (2004) Active and passive immunisation against Clostridium difficile diarrhoea and colitis. Vaccine 22:848\u2013856","journal-title":"Vaccine"},{"key":"574_CR93","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","volume":"359","author":"CP Kelly","year":"2008","unstructured":"Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359:1932\u20131940","journal-title":"N Engl J Med"},{"key":"574_CR94","first-page":"867","volume":"80","author":"FJ Tedesco","year":"1985","unstructured":"Tedesco FJ, Gordon D, Fortson WC (1985) Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 80:867\u2013868","journal-title":"Am J Gastroenterol"},{"key":"574_CR95","unstructured":"Nelson R (2007) Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev CD004610"},{"key":"574_CR96","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","volume":"41","author":"J Salcedo","year":"1997","unstructured":"Salcedo J, Keates S, Pothoulakis C et al (1997) Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 41:366\u2013370","journal-title":"Gut"},{"key":"574_CR97","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/17843286.1995.11718419","volume":"50","author":"M Warny","year":"1995","unstructured":"Warny M, Denie C, Delmee M, Lefebvre C (1995) Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A. Acta Clin Belg 50:36\u201339","journal-title":"Acta Clin Belg"},{"key":"574_CR98","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ajic.2006.06.007","volume":"35","author":"P Juang","year":"2007","unstructured":"Juang P, Skledar SJ, Zgheib NK et al (2007) Clinical outcomes of intravenous immunoglobulin in severe Clostridium difficile-associated diarrhoea. Am J Infect Control 35:131\u2013137","journal-title":"Am J Infect Control"},{"key":"574_CR99","doi-asserted-by":"crossref","unstructured":"Pillai A, Nelson R (2008) Probiotics for treatment of Clostridium difficile associated colitis in adults. Cochrane Database Syst Rev 1:CD004611","DOI":"10.1002\/14651858.CD004611.pub2"},{"key":"574_CR100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/141.1.92","volume":"141","author":"NS Taylor","year":"1980","unstructured":"Taylor NS, Bartlett JG (1980) Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. J Infect Dis 141:92\u201397","journal-title":"J Infect Dis"},{"key":"574_CR101","first-page":"220","volume":"77","author":"FJ Tedesco","year":"1982","unstructured":"Tedesco FJ (1982) Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 77:220\u2013221","journal-title":"Am J Gastroenterol"},{"key":"574_CR102","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3748\/wjg.15.1554","volume":"15","author":"P Hookman","year":"2009","unstructured":"Hookman P, Barkin JS (2009) Clostridium difficile associated infection, diarrhoea and colitis. World J Gastroenterol 15:1554\u20131580","journal-title":"World J Gastroenterol"},{"key":"574_CR103","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/506349","volume":"43","author":"TJ Louie","year":"2006","unstructured":"Louie TJ, Peppe J, Watt CK et al (2006) Tolevamer, a novel non-antibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhoea. Clin Infect Dis 43:411\u2013431","journal-title":"Clin Infect Dis"},{"key":"574_CR104","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.mcg.0000128988.13808.dc","volume":"38","author":"T Borody","year":"2004","unstructured":"Borody T, Warren E, Leis S, Surace R, Ashman O, Siarakas S (2004) Bacteriotherapy using faecal flora: toying with human motions. J Clin Gastroenterol 38:475\u2013483","journal-title":"J Clin Gastroenterol"},{"key":"574_CR105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004836-200307000-00012","volume":"37","author":"T Borody","year":"2003","unstructured":"Borody T, Warren E, Leis S, Surace R, Ashman O (2003) Treatment of ulcerative colitis using faecal bacteriotherapy. J Clin Gastroenterol 37:42\u201347","journal-title":"J Clin Gastroenterol"},{"key":"574_CR106","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1592\/phco.27.7.1029","volume":"27","author":"NL McMaster-Baxter","year":"2007","unstructured":"McMaster-Baxter NL, Musher DM (2007) Clostridium difficile: recent epidemiologic findings and advances in therapy. Pharmacotherapy 27:1029\u20131039","journal-title":"Pharmacotherapy"},{"key":"574_CR107","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/bmj.331.7515.498","volume":"331","author":"J Starr","year":"2005","unstructured":"Starr J (2005) Clostridium difficile\u2014associated diarrhoea: diagnosis and treatment. BMJ 331:498\u2013501","journal-title":"BMJ"},{"key":"574_CR108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bjs.6443","volume":"96","author":"D Gourevitch","year":"2009","unstructured":"Gourevitch D, Hawkey P (2009) Clostridium difficile infection and surgery. Br J Surg 96:3\u20134","journal-title":"Br J Surg"},{"key":"574_CR109","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/bmj.b1563","volume":"338","author":"SE Noblett","year":"2009","unstructured":"Noblett SE, Welfare M, Seymour K (2009) The role of surgery in Clostridium difficile colitis. BMJ 338:1196\u20131200","journal-title":"BMJ"},{"key":"574_CR110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1463-1318.2005.00876.x","volume":"8","author":"K Koss","year":"2005","unstructured":"Koss K, Clark MA, Sanders DSA, Morton D, Keighley MRB, Goh J (2005) The outcome of surgery in fulminant Clostridium difficile colitis. Col Dis 8:149\u2013154","journal-title":"Col Dis"},{"key":"574_CR111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2168.1998.00519.x","volume":"85","author":"K Synnott","year":"1998","unstructured":"Synnott K, Mealy K, Merry C, Kyne L, Keane C, Quill R (1998) Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 85:229\u2013231","journal-title":"Br J Surg"},{"key":"574_CR112","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/DCR.0b013e31819a69aa","volume":"52","author":"J Pepin","year":"2009","unstructured":"Pepin J, Truc Vo T, Boutros M et al (2009) Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 52:400\u2013405","journal-title":"Dis Colon Rectum"},{"key":"574_CR113","doi-asserted-by":"crossref","unstructured":"Hall JF, Berger D (2008) Outcome of colectomy for colitis: a plea for early surgical management. Am J Surg 196:384\u2013388 (Clostridium difficile)","DOI":"10.1016\/j.amjsurg.2007.11.017"},{"key":"574_CR114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/000313480807400105","volume":"74","author":"SO Ali","year":"2008","unstructured":"Ali SO, Welch JP, Dring RJ (2008) Early surgical intervention for fulminant pseudomembranous colitis. Am Surg 74:20\u201326","journal-title":"Am Surg"},{"key":"574_CR115","doi-asserted-by":"crossref","unstructured":"Nelson RL, Glenny AM, Song F (2009) Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev 1. doi: 10.1002\/14651858 . CD001181.pub3 (Art. No.: CD001181)","DOI":"10.1002\/14651858"},{"key":"574_CR116","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMcp011603","volume":"346","author":"JG Bartlett","year":"2002","unstructured":"Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhoea. N Engl J Med 346:1079\u20131084","journal-title":"N Engl J Med"},{"key":"574_CR117","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1078-5884(97)80195-5","volume":"14","author":"NW Bulstrode","year":"1997","unstructured":"Bulstrode NW, Bradbury AW, Barrett S et al (1997) Clostridium difficile colitis after aortic surgery. Eur J Vasc Endovasc Surg 14:217\u2013220","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"574_CR118","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s10350-004-0672-2","volume":"47","author":"WE Longo","year":"2004","unstructured":"Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE (2004) Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum 47:1620\u20131626","journal-title":"Dis Colon Rectum"},{"key":"574_CR119","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2214\/AJR.04.1697","volume":"186","author":"L Ash","year":"2006","unstructured":"Ash L, Baker ME, O\u2019Malley CM Jr, Gordon SM, Delaney CP, Obuchowski NA (2006) Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. Am J Roent 186:1393\u20131400","journal-title":"Am J Roent"},{"key":"574_CR120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archsurg.2007.46","volume":"143","author":"JC Byrn","year":"2008","unstructured":"Byrn JC, Maun DC, Gingol DS, Baril DT, Ozao JJ, Divino CM (2008) Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 143:150\u2013154","journal-title":"Arch Surg"},{"key":"574_CR121","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2008.02198.x","volume":"103","author":"MR Jaber","year":"2008","unstructured":"Jaber MR, Olafsson S, Fung WL, Reeves ME (2008) Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastro 103:3195\u20133203","journal-title":"Am J Gastro"},{"key":"574_CR122","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1308\/003588410X12518836439164","volume":"92","author":"K Gash","year":"2010","unstructured":"Gash K, Brown E, Pullyblank A (2010) Emergency subtotal colectomy for fulminant Clostridium difficile Colitis is a surgical solution considered for all patients? Ann R Coll Surg Engl 92:56\u201360","journal-title":"Ann R Coll Surg Engl"},{"key":"574_CR123","first-page":"491","volume":"116","author":"PA Lipsett","year":"1994","unstructured":"Lipsett PA, Samantary DK, Tam ML, Bartlett JG, Lillemoe KD (1994) Pseudomembranous colitis: a surgical disease? Surgery 116:491\u2013496","journal-title":"Surgery"},{"key":"574_CR124","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjsurg.2008.11.001","volume":"197","author":"CW Seder","year":"2009","unstructured":"Seder CW, Villalba MR Jr, Robbins J et al (2009) Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience. Am J Surg 197:302\u2013330","journal-title":"Am J Surg"},{"key":"574_CR125","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","volume":"14","author":"M Issa","year":"2008","unstructured":"Issa M, Ananthakrishnan N, Binion DG (2008) Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 14:1432\u20131442","journal-title":"Inflamm Bowel Dis"},{"key":"574_CR126","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.3748\/wjg.14.2794","volume":"14","author":"HJ Freeman","year":"2008","unstructured":"Freeman HJ (2008) Recent development on the role of Clostridium difficile in inflammatory bowel disease. World J Gastroenterol 14:2794\u20132796","journal-title":"World J Gastroenterol"},{"key":"574_CR127","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/gut.2007.128157","volume":"85","author":"T Monaghna","year":"2009","unstructured":"Monaghna T, Boswell T, Mahida R (2009) Recent advances in Clostridium difficile associated diseases. Postgrad Med J 85:152\u2013162","journal-title":"Postgrad Med J"},{"key":"574_CR128","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/gut.2007.128231","volume":"57","author":"AN Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG (2008) Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57:210\u2013256","journal-title":"Gut"},{"key":"574_CR129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gut.2007.137042","volume":"57","author":"CD Stone","year":"2008","unstructured":"Stone CD (2008) Prognosis in Clostridium difficile infection complication inflammatory bowel disease. Gut 57:150\u2013152","journal-title":"Gut"},{"key":"574_CR130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10620-009-0749-9","volume":"55","author":"D Jodorkovsky","year":"2010","unstructured":"Jodorkovsky D, Young Y, Abreu MT (2010) Clinical outcomes of patients with ulcerativecolitis and co-existing Clostridium difficile infection. Dig Dis Sci 55:415\u2013420","journal-title":"Dig Dis Sci"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-010-0574-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-010-0574-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-010-0574-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T11:41:22Z","timestamp":1635334882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-010-0574-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,8]]},"references-count":130,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s10151-010-0574-3","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,8]]}}}